In this issue:
Patterns of initial metastatic recurrence after RCC surgery
Survival following cytoreductive nephrectomy
42-month follow up of survival outcomes with nivolumab + ipilimumab vs sunitinib in RCC
Efficacy results from the JAVELIN renal 101 trial: avelumab + axitinib vs sunitinib in RCC
Atezolizumab + bevacizumab vs sunitinib in RCC and sarcomatoid features
Are immune checkpoint inhibitors a valid option for pRCC?
Bone metastases associated with poor prognosis in metastatic pRCC
Repeat ablative therapy in hereditary or multifocal renal cancer
Elevated pre-operative C-reactive protein associated with renal functional decline
Rates and predictors of perioperative complications in cytoreductive nephrectomy
Please login below to download this issue (PDF)